SARTINI, ALESSANDRO
SARTINI, ALESSANDRO
Dipartimento Chirurgico,Medico,Odontoiatrico e di Scienze Morfologiche con interesse Trapiantologico, Oncologico e di Medicina Rigenerativa
"Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not?
2015 Sartini, Alessandro; Di Girolamo, Maria; Bertani, Angela; Villa, Erica
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome
2016 Bedini, Andrea; De Maria, Nicola; Del Buono, Mariagrazia; Bianchini, Marcello; Mancini, Mauro; Binda, Cecilia; Brasacchio, Andrea; Orlando, Gabriella; Franceschini, Erica; Meschiari, Marianna; Sartini, Alessandro; Zona, Stefano; Paioli, Serena; Villa, Erica; Gyssens, Inge C.; Mussini, Cristina
BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence
2016 Sartini, Alessandro; Verga, Maria Chiara; Marzi, Luca; De Maria, Nicola; Villa, Erica
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection
2016 Sartini, Alessandro; Bianchini, Marcello; Schepis, Filippo; Marzi, Luca; De Maria, Nicola; Villa, Erica
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
2017 Sartini, Alessandro; Gitto, Stefano; Villa, Erica
Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study
2016 Di Girolamo, Maria; Sartini, Alessandro; Critelli, Rosina Maria; Bertani, Angela; Merighi, Alberto; Villa, Erica
Inflammatory bowel disease patients seem to develop non-alcoholic steatohepatitis (NASH) independently from an altered metabolic profile or active bowel disease
2016 Sartini, A.; Bianchini, M.; Gitto, S.; Di Girolamo, M.; Bertani, A.; Merighi, A.; Villa, E.
Letter: TNFα blockers and psoriasis: A 'reasonable paradox' - The role of TH-17 cells
2014 Sartini, A.; Di Girolamo, M.; Scarcelli, A.; Bertani, A.; Marzi, L.; Lasagni, C.; Merighi, A.; Villa, E.
Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases
2015 Sartini, A.; Leonardi, F.; Gitto, S.; Di Girolamo, M.; Villa, E.
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients
2018 Bianchini, Marcello; Cavani, Giulia; Bonaccorso, Ambra; Turco, Laura; Vizzutti, Francesco; Sartini, Alessandro; Gitto, Stefano; Merighi, Alberto; Banchelli, Federico; Villa, Erica; Schepis, Filippo
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
2018 Sartini, Alessandro; Gitto, Stefano; Bianchini, Marcello; Chiara Verga, Maria; Di Girolamo, Maria; Bertani, Angela; Del Buono, Mariagrazia; Schepis, Filippo; Lei, Barbara; De Maria, Nicola; Villa, Erica
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre
2018 DI GIROLAMO, Maria; Campomori, F; Spinella, A; Sartini, A; Sandri, G; Bertani, A; Verga, C; Merighi, A; Villa, E
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives
2018 Gitto, Stefano; Guarneri, Valeria; Sartini, Alessandro; Andreone, Pietro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not? | 1-gen-2015 | Sartini, Alessandro; Di Girolamo, Maria; Bertani, Angela; Villa, Erica | |
| Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome | 1-gen-2016 | Bedini, Andrea; De Maria, Nicola; Del Buono, Mariagrazia; Bianchini, Marcello; Mancini, Mauro; Binda, Cecilia; Brasacchio, Andrea; Orlando, Gabriella; Franceschini, Erica; Meschiari, Marianna; Sartini, Alessandro; Zona, Stefano; Paioli, Serena; Villa, Erica; Gyssens, Inge C.; Mussini, Cristina | |
| BactDNA as an Independent Risk Factor for Short-Term Crohn's Disease Recurrence | 1-gen-2016 | Sartini, Alessandro; Verga, Maria Chiara; Marzi, Luca; De Maria, Nicola; Villa, Erica | |
| Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection | 1-gen-2016 | Sartini, Alessandro; Bianchini, Marcello; Schepis, Filippo; Marzi, Luca; De Maria, Nicola; Villa, Erica | |
| Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? | 1-gen-2017 | Sartini, Alessandro; Gitto, Stefano; Villa, Erica | |
| Efficacy of a Novel Granulocyte Monocyte Apheresis Adsorber Device in the Treatment of Inflammatory Bowel Diseases: A Pilot Study | 1-gen-2016 | Di Girolamo, Maria; Sartini, Alessandro; Critelli, Rosina Maria; Bertani, Angela; Merighi, Alberto; Villa, Erica | |
| Inflammatory bowel disease patients seem to develop non-alcoholic steatohepatitis (NASH) independently from an altered metabolic profile or active bowel disease | 1-gen-2016 | Sartini, A.; Bianchini, M.; Gitto, S.; Di Girolamo, M.; Bertani, A.; Merighi, A.; Villa, E. | |
| Letter: TNFα blockers and psoriasis: A 'reasonable paradox' - The role of TH-17 cells | 1-gen-2014 | Sartini, A.; Di Girolamo, M.; Scarcelli, A.; Bertani, A.; Marzi, L.; Lasagni, C.; Merighi, A.; Villa, E. | |
| Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases | 1-gen-2015 | Sartini, A.; Leonardi, F.; Gitto, S.; Di Girolamo, M.; Villa, E. | |
| Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients | 1-gen-2018 | Bianchini, Marcello; Cavani, Giulia; Bonaccorso, Ambra; Turco, Laura; Vizzutti, Francesco; Sartini, Alessandro; Gitto, Stefano; Merighi, Alberto; Banchelli, Federico; Villa, Erica; Schepis, Filippo | |
| Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease | 1-gen-2018 | Sartini, Alessandro; Gitto, Stefano; Bianchini, Marcello; Chiara Verga, Maria; Di Girolamo, Maria; Bertani, Angela; Del Buono, Mariagrazia; Schepis, Filippo; Lei, Barbara; De Maria, Nicola; Villa, Erica | |
| The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre | 1-gen-2018 | DI GIROLAMO, Maria; Campomori, F; Spinella, A; Sartini, A; Sandri, G; Bertani, A; Verga, C; Merighi, A; Villa, E | |
| The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives | 1-gen-2018 | Gitto, Stefano; Guarneri, Valeria; Sartini, Alessandro; Andreone, Pietro |